Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹855.00
Market cap: ₹1,008 Cr
Revenue (annual): ₹853.6 Cr
Net profit (annual): ₹36.99 Cr
P/E (TTM): 27.2×Sector 47.4×
Promoter holding: 70.95%
FII holding: 5.28%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Management Change 2 Financial Results 2 Dividend 2 SME to Main Board Migration 1 Results Update 1 Other Announcement 1 Merger & Restructuring 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Sep 2026 18:36 IST NSE

Management Change

Remus Pharmaceuticals Management Change

Remus Pharmaceuticals Limited has appointed Mr. Ashutosh Naginbhai Valani as a Non-Executive Independent Director, effective September 2, 2026.

Read the filing ↗

20 May 2026 15:30 IST NSE

Management Change

Remus Pharmaceuticals Management Change

Remus Pharmaceuticals appointed Mr. Tapan Shah as Secretarial Auditor for FY 2026-2027. The appointment follows recommendation by the Audit Committee and Board approval.

Execution: FY 2026-27

Read the filing ↗